Travis Alvin Thompson sold $67k of BCYC
CHIEF ACCOUNTING OFFICER at BICYCLE THERAPEUTICS PLC. 4,595 shares at an average of $14.64, traded Jan 2, 2025, filed Jan 6, 2025.
Score components
- +15RoleOfficer
- +8Trade size$67k at market
- +5Share of holdings soldSold 13% of holdings
- +15Cluster8 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-000928, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 2, 2025 | AGrant or award Ordinary Shares10b5-1 | +17,500 | $0.00 | $0 | 36,741 | Jan 6, 2025 |
| Jan 2, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -1,750 | $14.09 | $25k | 34,991 | Jan 6, 2025 |
| Jan 3, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -159 | $14.75 | $2,345 | 34,832 | Jan 6, 2025 |
| Jan 6, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -2,686 | $15.00 | $40k | 32,146 | Jan 6, 2025 |
| Jan 2, 2025 | AGrant or award Employee Stock Option (right to buy)derivative10b5-1 | +43,500 | $0.00 | $0 | 43,500 | Jan 6, 2025 |
Related signals
Other insiders at BICYCLE THERAPEUTICS PLC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | BICYCLE THERAPEUTICS PLC | Jennifer Scott Perry Chief Operating Officer | $1,339 356 shares | -0% | |
| 30Weak | BICYCLE THERAPEUTICS PLC | Michael Skynner CHIEF SCIENTIFIC OFFICER | $8,534 2,445 shares | -2% | |
| 45Moderate | BICYCLE THERAPEUTICS PLC | Kevin Lee CHIEF EXECUTIVE OFFICER | $27k 7,805 shares | -1% | |
| 37Weak | BICYCLE THERAPEUTICS PLC | Travis Alvin Thompson Chief Financial Officer | $3,381 972 shares | -1% | |
| 30Weak | BICYCLE THERAPEUTICS PLC | Michael Charles Ferguson Hannay CHIEF PROD & SUPPLY CHAIN OFF | $6,319 1,814 shares | -2% | |
| 35Weak | BICYCLE THERAPEUTICS PLC | Robert Charles Swanton director | $12k 3,431 shares | -18% | |
| 15Weak | BICYCLE THERAPEUTICS PLC | Jennifer Scott Perry Chief Operating Officer | $5,313 1,500 shares | -2% | |
| 37Weak | BICYCLE THERAPEUTICS PLC | Alethia Young Chief Financial Officer | $1,446 204 shares | -0% | |
| 30Weak | BICYCLE THERAPEUTICS PLC | Travis Alvin Thompson CHIEF ACCOUNTING OFFICER | $2,205 306 shares | -1% | |
| 30Weak | BICYCLE THERAPEUTICS PLC | Michael Charles Ferguson Hannay CHIEF PROD & SUPPLY CHAIN OFF | $5,206 722 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.